Oculis Selects AGC Biologics’ Heidelberg Facility to Manufacture OCS-02
06 mai 2021 10h00 HE
|
AGC Biologics
Seattle, May 06, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced its partnership with Oculis to...